sulforaphane vs glutathione as a potential therapeutic agent: a comprehensive analysis of clinical trials and mechanistic insights Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates:
Description
Erythema was reported with use of the foam (up to 1%) and the gel (less than 1%)
Users should avoid consuming the product if the seal is broken upon arrival or if the product's color, aroma, or consistency changes over time
R.GolonkaR
Protein samples were separated by 412% SDS-PAGE, transferred onto PVDF membranes (GE Healthcare, Milan, Italy), and incubated with antibodies targeting and Alpha-Smooth Muscle Actin (catalog n A2547, Sigma-Aldrich)
